Page 1

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from OMEGA HEALTHCARE INVESTORS , INC . ( Exact Name of Registrant as Specified in its Charter ) Maryland ( Omega Healthcare Investors , Inc. ) ( State or other jurisdiction of incorporation or organization ) Registrant Omega Healthcare Investors , Inc. to 1-11316 ( Omega Healthcare Investors , Inc. ) ( Commission file number ) 303 International Circle , Suite 200 , Hunt Valley , MD 21030 ( Address of principal executive offices ) Title of Each Class Common Stock , $ .10 Par Value Securities registered pursuant to Section 12 ( g ) of the Act : None . Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No ( 410 ) 427-1700 ( Telephone number , including area code ) Securities Registered Pursuant to Section 12 ( b ) of the Act : Large accelerated filer Smaller reporting company Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes □ No 38-3041398 ( Omega Healthcare Investors , Inc. ) ( IRS Employer Identification No. ) Trading Symbol ( s ) OHI Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding twelve months ( or for such shorter period that the registrant was required to file such reports ) and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Indicate by check mark whether the registrant has submitted electronically , every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No Accelerated filer Emerging growth company Name of Exchange on Which Registered New York Stock Exchange Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . ( Check one :) Non - accelerated filer If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7 ( a ) ( 2 ) ( B ) of the Securities Act . Yes □ No Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Yes No 0 Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No The aggregate market value of the common stock Omega Healthcare Investors , Inc. held by non - affiliates was $ 6,747,008,166 as of June 30 , 2020 , the last business day of the registrant's most recently completed second fiscal quarter . The aggregate market value was computed using the $ 29.73 closing price per share for such stock on the New York Stock Exchange on such date . As of February 12 , 2021 , there were 231,776,284 shares of Omega Healthcare Investors , Inc. common stock outstanding . DOCUMENTS INCORPORATED BY REFERENCE Proxy Statement for the registrant's 2021 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission no later than 120 days after December 31 , 2020 , is incorporated by reference in Part III herein .